Variant report

Variant	nsv898933
Chromosome Location	chr12:26262137-26285006
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1744)
CpG islands
(count:1771)
Chromatin interactive
region (count:41)
LncRNA
region (count:7)
Mature miRNA
region (count: 0)
miRNA target
sites (count:1)

(count:1744 , 50 per page) page: 1 2 3 4 5 6 7 ... 35

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:26267502-26267837	K562	blood:	n/a	n/a
2	ARID3A	chr12:26267453-26267764	HepG2	liver:	n/a	n/a
3	ARID3A	chr12:26272411-26272750	K562	blood:	n/a	n/a
4	ARID3A	chr12:26272480-26272707	HepG2	liver:	n/a	n/a
5	ATF2	chr12:26267184-26267724	H1-hESC	embryonic stem cell:	n/a	n/a
6	ATF2	chr12:26265482-26265956	H1-hESC	embryonic stem cell:	n/a	n/a
7	ATF2	chr12:26267363-26267800	H1-hESC	embryonic stem cell:	n/a	n/a
8	ATF3	chr12:26267275-26267605	HepG2	liver:	n/a	chr12:26267473-26267493
9	ATF3	chr12:26267335-26267617	K562	blood:	n/a	chr12:26267473-26267493
10	ATF3	chr12:26267346-26267529	GM12878	blood:	n/a	chr12:26267473-26267493
11	ATF3	chr12:26267224-26267659	H1-hESC	embryonic stem cell:	n/a	chr12:26267473-26267493
12	ATF3	chr12:26267192-26267679	H1-hESC	embryonic stem cell:	n/a	chr12:26267473-26267493
13	ATF3	chr12:26267217-26267622	GM12878	blood:	n/a	chr12:26267473-26267493
14	BACH1	chr12:26277710-26278042	H1-hESC	embryonic stem cell:	n/a	n/a
15	BACH1	chr12:26266630-26267708	H1-hESC	embryonic stem cell:	n/a	n/a
16	BACH1	chr12:26269834-26270424	K562	blood:	n/a	n/a
17	BACH1	chr12:26274809-26274989	H1-hESC	embryonic stem cell:	n/a	n/a
18	BACH1	chr12:26266915-26267370	K562	blood:	n/a	n/a
19	BACH1	chr12:26269678-26270271	H1-hESC	embryonic stem cell:	n/a	n/a
20	BACH1	chr12:26275835-26276400	H1-hESC	embryonic stem cell:	n/a	n/a
21	BACH1	chr12:26278670-26279546	H1-hESC	embryonic stem cell:	n/a	chr12:26279132-26279146
22	BATF	chr12:26272321-26272670	GM12878	blood:	n/a	n/a
23	BCL3	chr12:26266658-26267752	A549	lung:	n/a	chr12:26267011-26267020 chr12:26267060-26267073 chr12:26267061-26267074
24	BCL3	chr12:26275865-26276455	A549	lung:	n/a	n/a
25	BCL3	chr12:26266695-26267303	A549	lung:	n/a	chr12:26267011-26267020 chr12:26267060-26267073 chr12:26267061-26267074
26	BHLHE40	chr12:26266634-26267951	GM12878	blood:	n/a	n/a
27	BHLHE40	chr12:26266733-26267904	HepG2	liver:	n/a	n/a
28	BHLHE40	chr12:26277805-26278178	K562	blood:	n/a	chr12:26278009-26278022
29	BHLHE40	chr12:26276160-26276375	GM12878	blood:	n/a	n/a
30	BHLHE40	chr12:26279355-26279675	K562	blood:	n/a	chr12:26279655-26279671 chr12:26279578-26279594 chr12:26279588-26279604 chr12:26279563-26279579 chr12:26279576-26279592
31	BHLHE40	chr12:26277742-26278210	HepG2	liver:	n/a	chr12:26278009-26278022
32	BHLHE40	chr12:26271417-26271667	GM12878	blood:	n/a	n/a
33	BHLHE40	chr12:26277643-26279750	GM12878	blood:	n/a	chr12:26279048-26279064 chr12:26278009-26278022 chr12:26279655-26279671 chr12:26279578-26279594 chr12:26279588-26279604 chr12:26279563-26279579 chr12:26279576-26279592
34	BHLHE40	chr12:26269852-26269861	K562	blood:	n/a	n/a
35	BHLHE40	chr12:26266746-26268202	K562	blood:	n/a	n/a
36	BHLHE40	chr12:26278916-26279701	HepG2	liver:	n/a	chr12:26279048-26279064 chr12:26279655-26279671 chr12:26279578-26279594 chr12:26279588-26279604 chr12:26279563-26279579 chr12:26279576-26279592
37	BHLHE40	chr12:26267315-26267588	HepG2	liver:	n/a	n/a
38	BHLHE40	chr12:26278582-26278614	K562	blood:	n/a	n/a
39	BHLHE40	chr12:26267188-26267690	HepG2	liver:	n/a	n/a
40	BHLHE40	chr12:26277835-26278079	A549	lung:	n/a	chr12:26278009-26278022
41	BHLHE40	chr12:26266777-26267661	A549	lung:	n/a	n/a
42	BRCA1	chr12:26265363-26266543	Hela-S3	cervix:	n/a	n/a
43	BRCA1	chr12:26266434-26266539	H1-hESC	embryonic stem cell:	n/a	n/a
44	BRCA1	chr12:26266840-26267687	Hela-S3	cervix:	n/a	n/a
45	BRCA1	chr12:26279146-26279568	Hela-S3	cervix:	n/a	n/a
46	BRCA1	chr12:26279022-26279045	H1-hESC	embryonic stem cell:	n/a	n/a
47	CBX3	chr12:26266826-26267826	K562	blood:	n/a	n/a
48	CCNT2	chr12:26279331-26279674	K562	blood:	n/a	n/a
49	CCNT2	chr12:26266853-26267940	K562	blood:	n/a	chr12:26267413-26267422 chr12:26266989-26266998 chr12:26267423-26267432
50	CCNT2	chr12:26275071-26275409	K562	blood:	n/a	n/a

(count:1771 , 50 per page) page: 1 2 3 4 5 6 7 ... 36

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:26278767-26278817	Hepatocyte	liver:	n/a
2	chr12:26267490-26267540	H1-hESC	embryonic stem cell:	embryo
3	chr12:26278767-26278817	Hepatocyte	liver:	n/a
4	chr12:26267490-26267540	H1-hESC	embryonic stem cell:	embryo
5	chr12:26282838-26282888	NHDF-neo	bronchial:	n/a
6	chr12:26279443-26279493	GM19239	blood:	n/a
7	chr12:26274368-26274418	SK-N-MC	brain:	n/a
8	chr12:26282838-26282888	ovcar-3	ovarian:	n/a
9	chr12:26267286-26267336	BE2_C	brain:	n/a
10	chr12:26267490-26267540	Hela-S3	cervix:	n/a
11	chr12:26262307-26262357	K562	blood:	n/a
12	chr12:26274563-26274613	MCF10A-Er-Src	breast:	n/a
13	chr12:26275050-26275100	HCF	heart:	n/a
14	chr12:26266049-26266099	HepG2	liver:	n/a
15	chr12:26267213-26267263	HAEpiC	amniotic membrane:	n/a
16	chr12:26262307-26262357	HCF	heart:	n/a
17	chr12:26279443-26279493	MCF-7	breast:	n/a
18	chr12:26277826-26277876	Hepatocyte	liver:	n/a
19	chr12:26273008-26273058	GM06990	blood:	n/a
20	chr12:26278677-26278727	SK-N-MC	brain:	n/a
21	chr12:26274368-26274418	NH-A	brain:	n/a
22	chr12:26276329-26276379	NHBE	bronchial:	n/a
23	chr12:26274563-26274613	NH-A	brain:	n/a
24	chr12:26277925-26277975	HCF	heart:	n/a
25	chr12:26274563-26274613	SK-N-SH_RA	brain:	n/a
26	chr12:26274368-26274418	AG10803	skin:	n/a
27	chr12:26267069-26267119	AG04450	lung:	fetal
28	chr12:26275383-26275433	HCM	heart:	n/a
29	chr12:26266049-26266099	NB4	blood:	n/a
30	chr12:26278128-26278178	ProgFib	skin:	n/a
31	chr12:26267213-26267263	SK-N-SH_RA	brain:	n/a
32	chr12:26276329-26276379	HCF	heart:	n/a
33	chr12:26273008-26273058	SAEC	small airway:	n/a
34	chr12:26279544-26279594	HCF	heart:	n/a
35	chr12:26277826-26277876	SKMC	muscle:	n/a
36	chr12:26279160-26279210	HL-60	blood:	n/a
37	chr12:26277826-26277876	HEK293	kidney:	embryo
38	chr12:26267490-26267540	GM19239	blood:	n/a
39	chr12:26274368-26274418	PANC-1	pancreas:	n/a
40	chr12:26278128-26278178	HUVEC	blood vessel:	n/a
41	chr12:26277925-26277975	AG09309	skin:	n/a
42	chr12:26275661-26275711	SK-N-MC	brain:	n/a
43	chr12:26278767-26278817	ECC-1	luminal epithelium:	n/a
44	chr12:26274368-26274418	NB4	blood:	n/a
45	chr12:26267286-26267336	NT2-D1	testis:	n/a
46	chr12:26278767-26278817	HCT-116	colon:	n/a
47	chr12:26267286-26267336	HCM	heart:	n/a
48	chr12:26282838-26282888	MCF-7	breast:	n/a
49	chr12:26278767-26278817	K562	blood:	n/a
50	chr12:26279160-26279210	HepG2	liver:	n/a

(count:41 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:26267272..26269559-chr12:26803313..26806107,3	MCF-7	breast:
2	chr12:26265385..26267169-chr12:26572814..26574483,2	MCF-7	breast:
3	chr12:26279728..26281468-chr12:26283213..26285101,2	MCF-7	breast:
4	chr12:26272137..26273093-chr12:26618088..26619005,4	K562	blood:
5	chr12:26265885..26268000-chr12:26325452..26327624,2	K562	blood:
6	chr12:26272067..26272967-chr12:26427154..26428088,3	MCF-7	breast:
7	chr12:26266595..26267505-chr8:130559843..130560755,2	NB4	blood:
8	chr12:26275273..26277209-chr12:26278660..26280315,2	K562	blood:
9	chr12:26265498..26267038-chr12:26270346..26272635,2	K562	blood:
10	chr12:26265973..26268501-chr12:26274861..26277671,2	K562	blood:
11	chr12:26249873..26250576-chr12:26272177..26272793,2	MCF-7	breast:
12	chr12:26264438..26267569-chr12:26570789..26574117,3	MCF-7	breast:
13	chr12:26272271..26272871-chr12:26306501..26307365,2	MCF-7	breast:
14	chr12:26269852..26272033-chr12:26274185..26277009,2	K562	blood:
15	chr12:26265923..26267917-chr12:26426739..26429196,2	K562	blood:
16	chr12:26266900..26267703-chr7:6120977..6121497,2	NB4	blood:
17	chr12:26272064..26273040-chr12:26462557..26463249,2	MCF-7	breast:
18	chr12:26274883..26277038-chr12:26421953..26424842,3	MCF-7	breast:
19	chr12:26274388..26277209-chr12:26277264..26280315,5	K562	blood:
20	chr12:26266512..26267013-chr12:65699501..65700001,2	NB4	blood:
21	chr12:26265498..26267129-chr12:26270346..26273975,3	K562	blood:
22	chr12:26179146..26181652-chr12:26265259..26267157,2	K562	blood:
23	chr12:26274372..26276820-chr12:26284434..26286268,2	MCF-7	breast:
24	chr12:26240929..26244393-chr12:26265760..26268742,3	MCF-7	breast:
25	chr12:26274388..26277209-chr12:26277264..26280315,5	K562	blood:
26	chr12:26275273..26277209-chr12:26278660..26280315,2	K562	blood:
27	chr12:26249759..26250646-chr12:26272207..26272972,2	MCF-7	breast:
28	chr12:26266368..26268567-chr12:26426374..26428182,2	MCF-7	breast:
29	chr12:26252876..26255008-chr12:26267017..26268657,2	MCF-7	breast:
30	chr12:26266140..26268120-chr12:26569477..26571454,2	MCF-7	breast:
31	chr12:26267001..26268720-chr12:26276171..26278000,2	K562	blood:
32	chr12:26266991..26268524-chr12:26793832..26795703,2	MCF-7	breast:
33	chr12:26272403..26273193-chr12:26803931..26805170,4	MCF-7	breast:
34	chr12:26252565..26258898-chr12:26263969..26269269,10	MCF-7	breast:
35	chr12:26277354..26279021-chr12:26281511..26283781,2	K562	blood:
36	chr12:26269560..26272553-chr12:26430642..26432199,2	MCF-7	breast:
37	chr12:26265498..26267038-chr12:26270346..26272635,2	K562	blood:
38	chr12:26268041..26270216-chr12:26273442..26275781,2	K562	blood:
39	chr12:26265498..26267129-chr12:26270346..26273975,3	K562	blood:
40	chr12:26279728..26281468-chr12:26283213..26285101,2	MCF-7	breast:
41	chr12:26259059..26261551-chr12:26262901..26265223,2	K562	blood:

(count:7 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-BHLHE41-1	chr12:26278439-26278685	ENSG00000256894.1
2	lnc-BHLHE41-1	chr12:26278439-26278514	ENSG00000256894.1
3	lnc-SSPN-3	chr12:26274985-26275085	NONHSAT027390
4	lnc-BHLHE41-1	chr12:26278246-26278345	ENSG00000256894.1
5	lnc-BHLHE41-1	chr12:26278088-26278345	ENSG00000256894.1
6	lnc-BHLHE41-1	chr12:26279332-26279550	ENSG00000256894.1
7	lnc-BHLHE41-1	chr12:26278916-26279017	ENSG00000256894.1

No data

(count:1 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	BHLHE41	hsa-miR-186-5p	chr12:26273218-26273239

Variant related genes	Relation type
BHLHE41	TF binding region
ENSG00000256894	TF binding region
SSPN	TF binding region
BHLHE41	CpG island
ENSG00000256894	CpG island
SSPN	CpG island
ENSG00000255750	chromatin interactions
ENSG00000231704	chromatin interactions
ENSG00000256894	chromatin interactions
ENSG00000123096	chromatin interactions
ENSG00000123095	chromatin interactions

Extended variants
information (count: 783 )
Associated
traits (count: 89 )

Variant overlapped rSNPs/rCNVs (count:783 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2620694	chr12:26262137-26262138	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs556557233	chr12:26262138-26262139	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs186734464	chr12:26262164-26262165	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs539310975	chr12:26262198-26262199	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs140660152	chr12:26262212-26262213	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs554440593	chr12:26262287-26262288	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs113431219	chr12:26262308-26262309	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs545123081	chr12:26262341-26262342	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs540369104	chr12:26262373-26262374	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs555172332	chr12:26262390-26262391	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs573639115	chr12:26262401-26262402	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs7300076	chr12:26262426-26262427	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs530803316	chr12:26262427-26262428	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs181963324	chr12:26262441-26262442	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs533083711	chr12:26262502-26262503	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs186586790	chr12:26262532-26262533	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs544889909	chr12:26262568-26262569	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs7300129	chr12:26262587-26262588	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs376806003	chr12:26262594-26262595	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs549116919	chr12:26262632-26262633	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs145808558	chr12:26262680-26262681	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs531798633	chr12:26262717-26262718	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs190958177	chr12:26262737-26262738	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs183146936	chr12:26262783-26262784	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs571647409	chr12:26262802-26262803	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs186175407	chr12:26262803-26262804	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs189853010	chr12:26262837-26262838	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs566315975	chr12:26262871-26262872	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs557491962	chr12:26262884-26262885	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs55694223	chr12:26262885-26262886	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs147995534	chr12:26262919-26262920	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs138090660	chr12:26262969-26262970	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs141694809	chr12:26262976-26262977	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs543880061	chr12:26263020-26263021	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs150500603	chr12:26263049-26263050	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs577213067	chr12:26263138-26263139	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs544951188	chr12:26263167-26263168	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs138373991	chr12:26263248-26263249	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs527542005	chr12:26263252-26263253	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs182556337	chr12:26263271-26263272	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs142723077	chr12:26263278-26263279	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs74074407	chr12:26263294-26263295	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs377375645	chr12:26263323-26263324	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs576553660	chr12:26263453-26263454	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs373884872	chr12:26263483-26263484	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs540243771	chr12:26263525-26263526	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs529971724	chr12:26263551-26263552	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs147428683	chr12:26263571-26263572	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs550288965	chr12:26263606-26263607	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs571715520	chr12:26263609-26263610	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:89)

Disease	PMID	Source
Malignant germ cell tumour	17285132	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Myxofibrosarcoma	16751306	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Acute myeloid leukemia	16864856	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Myelodysplastic syndrome	21251322	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	16397240	CNVD
Neurodevelopmental disorder	22521361	CNVD
Intracranial aneurysm	16715129	CNVD
Breast cancer	21509527	CNVD
Autism	22102821	CNVD
Follicular lymphoma	18703704	CNVD
Lung cancer	18438408	CNVD
Lung cancer	21911935	CNVD
Breast cancer	22048815	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Heart disease	21282601	CNVD
Ovarian cancer	20844748	CNVD
Lung cancer	17925434	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Gastric cancer	24379144	CNVD
Gastric cancer	19545448	CNVD
Lung cancer	20031968	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung adenocarcinoma	19826477	CNVD
Lung cancer	19525976	CNVD
Lung cancer	19826477	CNVD
Non-small cell lung cancer	19451690	CNVD
Non-small cell lung cancer	17504988	CNVD
Bipolar disorder	19114987	CNVD
Lung cancer	19671679	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	21364760	CNVD
Lung cancer	21569311	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:1769 , 50 per page) page: 1 2 3 4 5 6 7 ... 36

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:26251000-26265800	Weak transcription	HSMM	muscle
2	chr12:26255600-26264400	Weak transcription	Fetal Intestine Small	intestine
3	chr12:26257400-26262200	Enhancers	Skeletal Muscle Male	skeletal muscle
4	chr12:26258000-26262200	Weak transcription	HUES6 Cell Line	embryonic stem cell
5	chr12:26258200-26265000	Weak transcription	Fetal Intestine Large	intestine
6	chr12:26259000-26262200	Enhancers	Skeletal Muscle Female	skeletal muscle
7	chr12:26261800-26262600	Enhancers	iPS-18 Cell Line	embryonic stem cell
8	chr12:26261800-26262600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
9	chr12:26261800-26263600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
10	chr12:26261800-26263600	Enhancers	Adipose Nuclei	Adipose
11	chr12:26261800-26263800	Enhancers	Fetal Muscle Leg	muscle
12	chr12:26262000-26262200	Enhancers	Colon Smooth Muscle	Colon
13	chr12:26262000-26262200	Enhancers	Fetal Thymus	thymus
14	chr12:26262000-26262400	Enhancers	HUES48 Cell Line	embryonic stem cell
15	chr12:26262000-26262600	Enhancers	iPS-15b Cell Line	embryonic stem cell
16	chr12:26262000-26262600	Enhancers	iPS-20b Cell Line	embryonic stem cell
17	chr12:26262000-26262600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr12:26262000-26262600	Enhancers	Right Atrium	heart
19	chr12:26262000-26262800	Enhancers	H9 Cell Line	embryonic stem cell
20	chr12:26262000-26262800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
21	chr12:26262000-26263600	Enhancers	Psoas Muscle	Psoas
22	chr12:26262200-26262600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
23	chr12:26262200-26262800	Enhancers	H1 Cell Line	embryonic stem cell
24	chr12:26262200-26262800	Enhancers	Fetal Lung	lung
25	chr12:26262200-26262800	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
26	chr12:26262200-26263000	Enhancers	HUES64 Cell Line	embryonic stem cell
27	chr12:26262200-26263000	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
28	chr12:26262200-26263200	Enhancers	HUES6 Cell Line	embryonic stem cell
29	chr12:26262200-26263200	Weak transcription	Fetal Thymus	thymus
30	chr12:26262200-26266000	Weak transcription	Colon Smooth Muscle	Colon
31	chr12:26262400-26262600	Enhancers	Placenta	Placenta
32	chr12:26262400-26262600	Enhancers	Left Ventricle	heart
33	chr12:26262400-26262800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
34	chr12:26262400-26262800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
35	chr12:26262400-26262800	Enhancers	Pancreas	Pancrea
36	chr12:26262400-26263000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
37	chr12:26262400-26263000	Enhancers	NHLF	lung
38	chr12:26262400-26263400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
39	chr12:26262400-26263400	Enhancers	Fetal Muscle Trunk	muscle
40	chr12:26262400-26265400	Enhancers	ES-I3 Cell Line	embryonic stem cell
41	chr12:26262600-26262800	Enhancers	Duodenum Smooth Muscle	Duodenum
42	chr12:26262600-26263000	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
43	chr12:26262600-26263200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
44	chr12:26262600-26265400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
45	chr12:26262600-26265400	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
46	chr12:26262600-26265600	Weak transcription	Placenta	Placenta
47	chr12:26262600-26265800	Weak transcription	Left Ventricle	heart
48	chr12:26262600-26266600	Weak transcription	Right Atrium	heart
49	chr12:26262600-26266800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
50	chr12:26262800-26263200	Enhancers	Skeletal Muscle Female	skeletal muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links